Carcinoid syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:
* Theodor Langhans (1839–1915) was the first to describe the histology of a carcinoid tumor in 1867.
* Theodor Langhans (1839–1915) was the first to describe the histology of a carcinoid tumor in 1867.
* The term Carcinoid was given by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich in 1907.
* The term Carcinoid was given by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich in 1907.
* Siegfried Oberndorfer refered the carcinoid tumor as "benign carcinomas as they had distinct clinical entities and named them "karzinoide"(carcinoma-like).
* Siegfried Oberndorfer refered the carcinoid tumor as "benign carcinomas" as they had distinct clinical entities and named them "karzinoide"(carcinoma-like).
* Karzinoide or “carcinoma-like” describes the unique feature of behaving like a benign tumor despite resembling a carcinoma microscopically.
* Karzinoide or “carcinoma-like” describes the unique feature of behaving like a benign tumor despite resembling a carcinoma microscopically.
* Rapport and colleagues isolated and named serotonin (5-HT), initially identified as a vasoconstrictor substance in the serum.<ref name="pmid18100415">{{cite journal |vauthors=RAPPORT MM, GREEN AA, PAGE IH |title=Serum vasoconstrictor, serotonin; isolation and characterization |journal=J. Biol. Chem. |volume=176 |issue=3 |pages=1243–51 |date=December 1948 |pmid=18100415 |doi= |url=}}</ref>
* Rapport and colleagues isolated and named serotonin (5-HT), initially identified as a vasoconstrictor substance in the serum.<ref name="pmid18100415">{{cite journal |vauthors=RAPPORT MM, GREEN AA, PAGE IH |title=Serum vasoconstrictor, serotonin; isolation and characterization |journal=J. Biol. Chem. |volume=176 |issue=3 |pages=1243–51 |date=December 1948 |pmid=18100415 |doi= |url=}}</ref>
* Enterochromaffin cell, the carcinoid cell of origin, had been identified as early as 1897 by N. Kulchitsky (1856-1925).
* Enterochromaffin cell, cell of origin of carcinoid tumour had been identified as early as 1897 by N. Kulchitsky (1856-1925).
* F. Lembeck in 1953 established that enterochromaffin cells synthesizes and secretes serotonin and a major hormone responsible for carcinoid syndrom.<ref name="pmid14941051">{{cite journal |vauthors=ERSPAMER V, ASERO B |title=Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine |journal=Nature |volume=169 |issue=4306 |pages=800–1 |date=May 1952 |pmid=14941051 |doi= |url=}}</ref><ref name="pmid16882492">{{cite journal |vauthors=Sippel RS, Chen H |title=Carcinoid tumors |journal=Surg. Oncol. Clin. N. Am. |volume=15 |issue=3 |pages=463–78 |date=July 2006 |pmid=16882492 |doi=10.1016/j.soc.2006.05.002 |url=}}</ref>
* F. Lembeck in 1953 established that enterochromaffin cells synthesizes and secretes serotonin and a major hormone responsible for carcinoid syndrome.<ref name="pmid14941051">{{cite journal |vauthors=ERSPAMER V, ASERO B |title=Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine |journal=Nature |volume=169 |issue=4306 |pages=800–1 |date=May 1952 |pmid=14941051 |doi= |url=}}</ref><ref name="pmid16882492">{{cite journal |vauthors=Sippel RS, Chen H |title=Carcinoid tumors |journal=Surg. Oncol. Clin. N. Am. |volume=15 |issue=3 |pages=463–78 |date=July 2006 |pmid=16882492 |doi=10.1016/j.soc.2006.05.002 |url=}}</ref>


==References==
==References==

Revision as of 16:28, 18 December 2018

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome historical perspective

CDC on Carcinoid syndrome historical perspective

Carcinoid syndrome historical perspective in the news

Blogs on Carcinoid syndrome historical perspective

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Carcinoid syndrome was first described by Siegfried Oberndorfer, a German pathologist in 1907. Endocrine related properties of carcinoid syndrome was described by Gosset and Masson in 1914.[1]

Historical Perspective

  • Theodor Langhans (1839–1915) was the first to describe the histology of a carcinoid tumor in 1867.
  • The term Carcinoid was given by Siegfried Oberndorfer, a German pathologist at the University of Munich in 1907.
  • Siegfried Oberndorfer refered the carcinoid tumor as "benign carcinomas" as they had distinct clinical entities and named them "karzinoide"(carcinoma-like).
  • Karzinoide or “carcinoma-like” describes the unique feature of behaving like a benign tumor despite resembling a carcinoma microscopically.
  • Rapport and colleagues isolated and named serotonin (5-HT), initially identified as a vasoconstrictor substance in the serum.[2]
  • Enterochromaffin cell, cell of origin of carcinoid tumour had been identified as early as 1897 by N. Kulchitsky (1856-1925).
  • F. Lembeck in 1953 established that enterochromaffin cells synthesizes and secretes serotonin and a major hormone responsible for carcinoid syndrome.[3][4]

References

  1. Tsoucalas G, Karamanou M, Androutsos G (2011). "The eminent German pathologist Siegfried Oberndorfer (1876-1944) and his landmark work on carcinoid tumors". Ann Gastroenterol. 24 (2): 98–100. PMC 3959292. PMID 24713679.
  2. RAPPORT MM, GREEN AA, PAGE IH (December 1948). "Serum vasoconstrictor, serotonin; isolation and characterization". J. Biol. Chem. 176 (3): 1243–51. PMID 18100415.
  3. ERSPAMER V, ASERO B (May 1952). "Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine". Nature. 169 (4306): 800–1. PMID 14941051.
  4. Sippel RS, Chen H (July 2006). "Carcinoid tumors". Surg. Oncol. Clin. N. Am. 15 (3): 463–78. doi:10.1016/j.soc.2006.05.002. PMID 16882492.

Template:WH Template:WS

References

Template:WS Template:WH